BMJ Best Practice

参考文献

参考文章

1.  Taniegra ED. Hyperparathyroidism. Am Fam Physician. 2004;69:333-339.

2.  Vieth R. Vitamin D supplementation, 25-hydroxyvitamin D concentrations, and safety. Am J Clin Nutr. 1999;69:842-856.

3.  Bilezikian JP, Potts JT Jr, Fuleihan G el-H, et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab. 2002;87:5353-5361.

4.  Eigelberger MS, Cheah WK, Ituarte PH, et al. The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited? Ann Surg. 2004;239:528-535.

5.  Jacobs TP, Bilezikian JP. Clinical review: rare causes of hypercalcemia. J Clin Endocrinol Metab. 2005;90:6316-6322.

6.  Alberta Medical Association. Toward Optimized Practice: laboratory endocrine testing guidelines: hypercalcemia. Jan 2008 [internet publication].

7.  Medarov BI. Milk-alkali syndrome. Mayo Clin Proc. 2009;84:261-267.

8.  Walsh J, Gittoes N, Selby P, the Society for Endocrinology Clinical Committee. Society for Endocrinology Endocrine emergency guidance: Emergency management of acute hypercalcaemia in adult patients. Endocrine Connect. 2016;5:G9–G11.

9.  Mirrakhimov AE. Hypercalcemia of malignancy: An update on pathogenesis and management. N Am J Med Sci. 2015;7(11):483–493.

使用此内容应接受我们的免责声明。